Delivery of Medications for Chemotherapy Programs
We are seeking a supplier for medications used in the hospital's oncology chemotherapy and treatment programs. Specific quantities and details are provided in the attached forms.
CONTRACTING AUTHORITY
Name
UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE
City
Szczecin
Country
PL
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33652100, Antineoplastic agents.
Other CPV
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
33610000, Medicinal products for the alimentary tract and metabolism.
33622200, Antihypertensives.
LOTS (12)
Medikamente für die Krebspoliklinik C.16
Medikamente für die Krebsbehandlung C.24
Medikamente für die Krebsbehandlung C.0.01/C.26
Unterstützende Medikamente gegen Übelkeit bei Chemotherapie C.26
Unterstützende Medikamente gegen Übelkeit bei Chemotherapie C.0.09
Medikamente für die Chemotherapie
Medikamente für die Chemotherapie
Medikamente für die Chemotherapie C.57.2
Medikamente für die Chemotherapie C.21.a./C.21.b
Medikamente für das Programm zur Behandlung von Gebärmutterkrebs B.148
Medikamente für das Programm zur Behandlung von fortgeschrittenem Darmkrebs B.4
Medikamente für das Programm zur Behandlung von pulmonaler arterieller Hypertonie B.31
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
27 days remaining(LOT-0001)
Published